Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric antigen receptor T regulatory cells for the treatment of atherosclerosis

Chimeric antigen receptor T regulatory cells for the treatment of atherosclerosis

US Patent 12473342 · Granted Nov 18, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Switch costimulatory receptors2025
Compositions and methods for generating a persisting population of T cells usefu2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
Altering gene expression in cart cells and uses thereof2025
Use of trans-signaling approach in chimeric antigen receptors2025
Methods for improving the efficacy and expansion of immune cells2025
Use of the CD2 signaling domain in second-generation chimeric antigen receptors2025
Use of the CD2 signaling domain in second-generation chimeric antigen receptors2025
Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against 2025
Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against 2025
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor2025
Compositions and methods for T cell delivery of therapeutic molecules2025